SEC Filings | Portage Biotech

View all our SEC Filings

Filing date	Description	Form	Filing Group	View
Nov 30, 2016	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	Current Reports	0001095435-16-000067.pdf 0001095435-16-000067.rtf View HTML
Dec 9, 2016	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	Current Reports	0001095435-16-000068.pdf 0001095435-16-000068.rtf View HTML
Feb 27, 2017	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	Current Reports	0001393905-17-000036.pdf 0001393905-17-000036.rtf 0001393905-17-000036.xls View HTML
Mar 14, 2017	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	Current Reports	0001334589-17-000002.pdf 0001334589-17-000002.rtf View HTML
Mar 20, 2017	Securities offered to employees pursuant to employee benefit plans	S-8	Registration Statements	0001393905-17-000066.pdf 0001393905-17-000066.rtf 0001393905-17-000066.xls View HTML
Apr 10, 2017	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	Current Reports	0001334589-17-000008.pdf 0001334589-17-000008.rtf View HTML
Apr 12, 2017	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	Current Reports	0001334589-17-000011.pdf 0001334589-17-000011.rtf View HTML
May 3, 2017	Initial filing by director officer or owner of more than ten percent.	3	3,4,5	0001209191-17-029854.pdf 0001209191-17-029854.rtf View HTML
May 8, 2017	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	Current Reports	0001334589-17-000012.pdf 0001334589-17-000012.rtf View HTML
May 10, 2017	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	Current Reports	0001334589-17-000013.pdf 0001334589-17-000013.rtf View HTML

Data provided by Kaleidoscope.